rss
J Clin Pathol 2007;60:173-179 doi:10.1136/jcp.2005.035113
  • Original article

STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation

  1. Silke Lassmann1,*,
  2. Ingrid Schuster1,*,
  3. Axel Walch2,
  4. Heike Göbel1,
  5. Uta Jütting3,
  6. Frank Makowiec4,
  7. Ulrich Hopt4,
  8. Martin Werner1
  1. 1Institut für Parthologie, Universitätsklinikum Freiburg, Freiburg, Germany
  2. 2Institut für Pathologie, GSF-Forschungszentrum für Umwelt und Gesundheit, Neuherberg, Germany
  3. 3Institut für Biomathematik und Biometrie, GSF-Forschungszentrum für Umwelt und Gesundheit, Neuherberg, Germany
  4. 4Chirugische Klinik, Universitätsklinikum Freiburg, Freiburg, Germany
  1. Correspondence to:
 Dr S Lassmann
 Institut für Parthologie, Universitätsklinikum 19106 Freiburg, Breisacherstrasse 115a, Germany; silke.lassmann{at}uniklinik-freiburg.de
  • Accepted 27 January 2006

Abstract

Aims: To evaluate mRNA and protein expression of signal transducers and activators of transcription (STAT)3 in colorectal carcinomas (CRCs) and to define the association of STAT3 activity with the STAT3-inducible targets cyclin D1, survivin, Bcl-xl and Mcl-1.

Materials and methods: Matching serial sections of normal colonic epithelium and invasive CRCs (n = 32) were subjected to quantitative reverse transcriptase polymerase chain reaction specific to STAT3, cyclin D1, survivin, Bcl-xl and Mcl-1, as well as immunohistochemistry. For STAT3 immunohistochemistry, two antibodies, recognising unphosphorylated (UP-) and phosphorylated (tyr705, P-) STAT3 were used. Ki-67 (MIB-1) staining was included as a proliferation marker.

Results: Compared with normal colonic epithelium, UP-STAT3 and P-STAT3 (p = 0.023 and 0.006) protein expression and expression of its associated targets cyclin D1, survivin and Bcl-xl were significantly (all p<0.001) increased in carcinoma. In carcinomas, STAT3 (p = 0.019) and Bcl-xl (p = 0.001) mRNAs were correlated with lymph node status. Moreover, nuclear P-STAT3 protein expression (active state) was associated with the expression of its target genes Bcl-xl (p = 0.038) and survivin (p = 0.01) as well as with Ki-67 (p = 0.017). By contrast, cytoplasmic UP-STAT was significantly linked to Bcl-xl mRNA (p = 0.024) and protein (p = 0.001) as well as to cytoplasmic survivin protein expression (p = 0.019).

Conclusion: Both inactive (UP-STAT3) and active (P-STAT3) STAT3 proteins are markedly increased in invasive CRCs. This is associated with Bcl-xl and survivin induction, increased proliferation and lymph node metastasis. This study therefore provides the basis for further examination of the prognostic or predictive value of these molecular markers in CRC.

Footnotes

  • * These authors contributed equally to the work.

  • Competing interests: None declared.

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar